Your browser doesn't support javascript.
loading
Water-stable hydrophilic metal organic framework composite for the recognition of N-glycopeptides during diabetes progression by mass spectrometry.
Liu, Shuangshuang; Wang, Yang; Weng, Lingxiao; Wu, Jiaqi; Man, Qiuhong; Xia, Yan; Huang, Li-Hao.
Afiliação
  • Liu S; Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200438, China.
  • Wang Y; Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438, China.
  • Weng L; Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438, China.
  • Wu J; Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200438, China.
  • Man Q; Department of Clinical Laboratory, Shanghai Fourth People's Hospital, Tongji University, Shanghai, 200434, China. Manqiuhong307@163.com.
  • Xia Y; Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438, China. jyxiayan@nbt.edu.cn.
  • Huang LH; School of Materials Science and Engineering, NingboTech University, Ningbo, 315100, China. jyxiayan@nbt.edu.cn.
Mikrochim Acta ; 191(1): 11, 2023 12 06.
Article em En | MEDLINE | ID: mdl-38055058
A hydrophilic Al-MOFs composite was prepared using cheap and available reagents in water via a suitable large-scale production, an economical and environment-friendly method for capturing N-glycopeptides. The prepared Al-MOFs composite with high hydrolytically stable and hydrophilic 1D channels exhibits an ultralow detection limit (0.5 fmol/µL), and excellent reusability (at least 10 cycles) in the capture of N-glycopeptides from standard bio-samples. Interestingly, the Al-MOFs composite also shows remarkable performance in practical applications, where 300 N-glycopeptides ascribed to 124 glycoproteins were identified in 1 µL human serum and were successfully applied in profiling the differences of N-glycopeptides during diabetes progression. Moreover, 12 specific glycoproteins used as biomarkers to accurately distinguish the progression of diabetes are identified. The present work provides a potential commercial method for large-scale glycoproteomics research in complex clinical samples while offering new guidance for the precise diagnosis of diabetes progression.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Estruturas Metalorgânicas Limite: Humans Idioma: En Revista: Mikrochim Acta Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Estruturas Metalorgânicas Limite: Humans Idioma: En Revista: Mikrochim Acta Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China